Heilbrigðisskýrslur - 01.12.1969, Qupperneq 92

Heilbrigðisskýrslur - 01.12.1969, Qupperneq 92
1969 — 90 — to the patient’s own doctor to use his discretion in the individual case (Department of Health and Social Security, 1970b). Should a doctor decide to offer vaccine under such circumstances it is desirable to have a preliminary serological test which can be obtained through the Public Health Laboratory Service; only those women found to be seronegative to rubella virus should be considered for vaccination. It is important to be sure that a woman is not pregnant at the time of vaccination or for two months afterwards. B.59. Routine vaccination was begun on lst September 1970, initial priority being given to girls in their 14th year (i. e. aged 13 years). In order to facilitate the vaccination programme in its early stages vaccine was made available without cost to local authorities up to 31st March 1971. This was to enable them during that period to offer vaccination to all girls in their 14th year (Department of Health and Social Secu- rity, 1970c). 3.60. The aim of the vaccination programme is not to eradicate rubella from the community, but rather to protect girls before they reach the childbearing age, and thus to reduce and finally, it is hoped, eliminate the risk of fetal abnormality due to rubella in early pregnancy. It has been estimated that about 200 children are born in England and Wales with congenital rubella defects in a non-epidemic year but, of course, the number would be greatly increased following an epidemic. In order to assess the effect of vaccination on the incidence of congenital ru- bella defects a careful plan for maternal surveillance has been drawn up by Dr. J. A. Dudgeon, the Hospital for Sick Children, Great Ormond Street, London and Professor R. W. Smithells, Department of Paediat- rics, University of Leeds at the behest of the Joint Committee on Vaccination and Immunization. It is hoped that this plan, which is essentially an extension of a scheme which is already being operated by a number of paediatricians, will be inaugurated in 1971.“ Prófessor Margrét Guðnadóttir hefur látið í té eftirfarandi greinar- gerð um bólusetningu gegn rauðum hundum: Auk þess sem rubella-veira skaðar fóstur, ef móðir veikist á fyrstu vikum meðgöngutíma, hefur rubella einnig valdið fósturskemmdum, þar sem móðir hafði sjúkdóminn rétt áður en hún varð ófrísk. Börn, sem fæðast með galla af völdum rubella-fóstursýkingar, skilja veiruna út í þvagi og saur marga mánuði eftir fæðingu. Má finna veiruna í vefjum þessara barna a. m. k. tveimur árum eftir fæðingu. Þessi börn eru því smitberar. Þau fæðast þó með miklu magni af mót- efnum, sem fóstrið sjálft hefur myndað in utero, en eru ekki komin gegnum fylgju frá móður. Þessi mótefni koma ekki í veg fyrir útskilnað
Qupperneq 1
Qupperneq 2
Qupperneq 3
Qupperneq 4
Qupperneq 5
Qupperneq 6
Qupperneq 7
Qupperneq 8
Qupperneq 9
Qupperneq 10
Qupperneq 11
Qupperneq 12
Qupperneq 13
Qupperneq 14
Qupperneq 15
Qupperneq 16
Qupperneq 17
Qupperneq 18
Qupperneq 19
Qupperneq 20
Qupperneq 21
Qupperneq 22
Qupperneq 23
Qupperneq 24
Qupperneq 25
Qupperneq 26
Qupperneq 27
Qupperneq 28
Qupperneq 29
Qupperneq 30
Qupperneq 31
Qupperneq 32
Qupperneq 33
Qupperneq 34
Qupperneq 35
Qupperneq 36
Qupperneq 37
Qupperneq 38
Qupperneq 39
Qupperneq 40
Qupperneq 41
Qupperneq 42
Qupperneq 43
Qupperneq 44
Qupperneq 45
Qupperneq 46
Qupperneq 47
Qupperneq 48
Qupperneq 49
Qupperneq 50
Qupperneq 51
Qupperneq 52
Qupperneq 53
Qupperneq 54
Qupperneq 55
Qupperneq 56
Qupperneq 57
Qupperneq 58
Qupperneq 59
Qupperneq 60
Qupperneq 61
Qupperneq 62
Qupperneq 63
Qupperneq 64
Qupperneq 65
Qupperneq 66
Qupperneq 67
Qupperneq 68
Qupperneq 69
Qupperneq 70
Qupperneq 71
Qupperneq 72
Qupperneq 73
Qupperneq 74
Qupperneq 75
Qupperneq 76
Qupperneq 77
Qupperneq 78
Qupperneq 79
Qupperneq 80
Qupperneq 81
Qupperneq 82
Qupperneq 83
Qupperneq 84
Qupperneq 85
Qupperneq 86
Qupperneq 87
Qupperneq 88
Qupperneq 89
Qupperneq 90
Qupperneq 91
Qupperneq 92
Qupperneq 93
Qupperneq 94
Qupperneq 95
Qupperneq 96
Qupperneq 97
Qupperneq 98
Qupperneq 99
Qupperneq 100
Qupperneq 101
Qupperneq 102
Qupperneq 103
Qupperneq 104
Qupperneq 105
Qupperneq 106
Qupperneq 107
Qupperneq 108
Qupperneq 109
Qupperneq 110
Qupperneq 111
Qupperneq 112
Qupperneq 113
Qupperneq 114
Qupperneq 115
Qupperneq 116
Qupperneq 117
Qupperneq 118
Qupperneq 119
Qupperneq 120
Qupperneq 121
Qupperneq 122
Qupperneq 123
Qupperneq 124
Qupperneq 125
Qupperneq 126
Qupperneq 127
Qupperneq 128
Qupperneq 129
Qupperneq 130
Qupperneq 131
Qupperneq 132
Qupperneq 133
Qupperneq 134
Qupperneq 135
Qupperneq 136
Qupperneq 137
Qupperneq 138
Qupperneq 139
Qupperneq 140
Qupperneq 141
Qupperneq 142
Qupperneq 143
Qupperneq 144
Qupperneq 145
Qupperneq 146
Qupperneq 147
Qupperneq 148
Qupperneq 149
Qupperneq 150
Qupperneq 151
Qupperneq 152
Qupperneq 153
Qupperneq 154
Qupperneq 155
Qupperneq 156
Qupperneq 157
Qupperneq 158
Qupperneq 159
Qupperneq 160
Qupperneq 161
Qupperneq 162
Qupperneq 163
Qupperneq 164
Qupperneq 165
Qupperneq 166
Qupperneq 167
Qupperneq 168
Qupperneq 169
Qupperneq 170
Qupperneq 171
Qupperneq 172
Qupperneq 173
Qupperneq 174
Qupperneq 175
Qupperneq 176

x

Heilbrigðisskýrslur

Direct Links

Hvis du vil linke til denne avis/magasin, skal du bruge disse links:

Link til denne avis/magasin: Heilbrigðisskýrslur
https://timarit.is/publication/1524

Link til dette eksemplar:

Link til denne side:

Link til denne artikel:

Venligst ikke link direkte til billeder eller PDfs på Timarit.is, da sådanne webadresser kan ændres uden advarsel. Brug venligst de angivne webadresser for at linke til sitet.